Cervical intraepithelial neoplasia (CIN), also known as cervical dysplasia, is the abnormal growth of cells (neoplasia) or lesions on your outer cervix lining (intraepithelial). CIN can be ...

A new HPV vaccine induced regression of precancerous cervical lesions in 50% of patients and led to viral clearance in some ...

Here are 5 important questions to ask if you’ve been told you have cervical dysplasia: ...

The risk of developing cervical neoplasia 8 years after human papillomavirus (HPV) testing was similar to 3 years after a ...

Innovations in screening for cervical neoplasia include speculoscopy, which is intended to supplement the Pap smear, and automated review of Pap smears, which is currently intended to aid in ...

In those with grade 3 cervical intraepithelial neoplasia (CIN3), cells are already on the path toward malignancy. If left untreated, approximately one-third of these cases progress to cervical ...

Another term for cervical dysplasia is cervical intraepithelial neoplasia, or CIN. The exact cause of cervical dysplasia is not known, however it has been linked to the human papillomavirus (HPV).

“Our findings demonstrate that the therapeutic vaccine Vvax001 is safe, well-tolerated, and effective in eradicating HPV16-associated CIN3 lesions and clearing the underlying persistent HPV16 ...

Human papillomavirus (HPV) vaccines are in wide use around the world owing to the widespread implementation of immunization programs for young girls before they become sexually active. The phase ...

The Papanicolaou (Pap) smear is commonly used to screen for cervical cancer and since its ... screen for high-grade cervical intraepithelial neoplasia. Women with positive test results underwent ...

Fifty percent of patients with CIN3 had histopathological complete response; 63% had HPV16 clearance. HealthDay News — For patients with human papillomavirus (HPV) type 16 (HPV16)-positive ...